Photodynamic Therapy (PDT) Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, UK, Germany, France, China - Size and Forecast 2023-2027

Published: Oct 2023 Pages: 150 SKU: IRTNTR75776

Photodynamic Therapy (PDT) Market Size 2023-2027

The Global Photodynamic Therapy Market size is estimated to grow by USD 2.05 billion at a CAGR of 8.22% between 2022 and 2027. 

Photodynamic therapy is a growing, popular, and reliable method to treat cancer. Early detection of cancer is driving the market. Factors such as physical inactivity and excessive tobacco and alcohol consumption can cause lung, stomach, kidney, head, neck, and larynx cancer. As there is a rise in cancer cases, the dependence on photodynamic therapy is increasing significantly. This demand also promotes manufacturers to develop advanced and upgraded versions of products during the forecast period. Hence, the contribution of all these factors is expected to propel the growth of the market during the forecast period.

Study Period 2023-2027
Base Year For Estimation

2022

CAGR 8.22%
Forecast period

2023-2027

Fastest Growing Region

North America at 36%

Largest Segment

Application

Buy Now Full Report and Discover more

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Dynamics

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. 

Significant Trends

An increase in R&D and advances in technology is the key driver for the growth of the market. Manufacturers and market players have raised their investments in R&D to develop novel therapies for cancer treatment. These approaches are expected to support the development of new photodynamic therapy. A recently published review in dermatology and therapy proves that photodynamic therapy is offered with reduced toxicity for patients with skin conditions such as actinic keratosis (AK).

Moreover, many advances in technology happened during the post-genomic era to detect cancer cells without invasive and expensive surgery. These advances result in the development of technologies such as DNA sequencing, innovative biomarker discovery, drug delivery methods, and capillary electrophoresis. These technologies also help physicians to detect and quantify specific DNA or RNA sequences and proteins for early prediction and treatment of diseases. In the area of oncology, the use of these technologies has helped physicians obtain a better understanding of the pathogenesis of cancer. These trends are expected to support the market growth and trends during the forecast period.

Major Challenges

The high cost of treatment is the major challenge to the growth of the market. Patients' financial burden and overall treatment costs are rising as a result of cancers' long-term treatment requirements. In addition to the lengthy duration of the treatment, the utilized therapies, particularly targeted therapies like photodynamic therapy, are extremely costly. Biologics are included in targeted therapy. Their development and production require extremely sophisticated and advanced procedures, which raises their manufacturing cost and, consequently, sales price.

Moreover, the cost of these treatments is high because of the advanced procedures involved in developing monoclonal antibodies. companies required high-cost to manufacture a monoclonal antibody. It also involves several processes, from immunization and serum screening to splenocyte fusion and single-cell cloning. These processes require sophisticated research procedures and advanced equipment which are expensive. However manufacturers and healthcare providers financially support patients undergoing photodynamic therapies, and their high cost is a major challenge that will impede the market growth during the forecast period

Buy Now Full Report and Discover More

Market Segmentation

Application Analysis 

The market share growth by the cancer segment will be significant during the forecast period.PDT  designed to destroy cancerous and precancerous cells after light activation is designed as a two-stage treatment that combines light energy with a drug (photosensitizer). Cancer is a disease in which the body cells grow uncontrollably and spread to other body parts. It is caused due to changes or mutations to the DNA within the cells. Factors such as age, lifestyle habits, family history or inherited family condition, and prolonged chronic diseases can address raise the risk of occurrence of cancer.

Get a glance at the market contribution of various segments View a PDF Sample

The cancer segment was valued at USD 1.11 billion in 2017. Photodynamic therapy is a commonly used therapy in treating cancer globally. This therapy mainly uses a drug activated by the light agent which is called a photosensitizer which is mainly used to kill cancer cells. A laser or light-emitting diode (LED) is used as a source of light. When the cancer cells that have absorbed photosensitizers and drugs are exposed to light.  The oxygen radical produced from the photosensitizers, when exposed to light, kills the cancer cells with the specific wavelength. It is also useful in treating tumor cells. Hence, the role of PDT in treating cancer drives the growth of the market during the forecast period.

Product Analysis

Photodynamic drugs are by and large utilized in photodynamic treatment in which the photosensitizer specialist is actuated by light to kill disease cells. The main purpose of a photosensitizer agent is to transfer the energy into another molecule either directly or by a chemical reaction and to absorb light. The most common photosensitizing medications include amiodarone, chlorpromazine, nalidixic acid, and doxycycline.  Factors such as increasing attention toward new anti-cancer therapies, such as immunotherapy are likely to drive the demand for photosensitizer drug segmentation. Hence, all these factors will propel the growth of the photosensitizer drugs segmentation in the global photodynamic

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 36% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Due to the increase in the incidence of skin diseases and cancer, the market for PDT is rising in this region. Factors such as increasing awareness about PDT benefits, the rise in adoption of face photodynamic therapy, and photodynamic acne therapy are driving the market during the forecast period. 

Buy Now Full Report and Discover More

Key Photodynamic Therapy Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The market trends and analysis report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

  • Biofrontera AG
  • BIOLASE Inc.
  • biolitec AG
  • Galderma SA
  • II VI Inc.
  • IRIDEX Corp.
  • Lotus Global Group Inc.
  • LUMIBIRD SA
  • Lutronic Inc
  • Modulight Inc.
  • Photocure ASA
  • Pinnacle Biologics Inc.
  • Quanta Systems Spa
  • Soligenix Inc.
  • SpectraCure AB
  • Sun Pharmaceutical Industries Ltd.
  • SUS Advancing Technology Co. Ltd.
  • Theralase Technologies Inc.
  • Eufoton srl

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Customer Landscape

The market growth analysis report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market forecasting report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Customer Landscape

Market Analyst Overview

The Photodynamic Therapy (PDT) market has emerged as a promising avenue in treating various skin disorders and malignancies, offering minimally invasive procedures with reduced side effects. Recognized by organizations like the FDA and the World Health Organization (WHO), PDT utilizes light activation of photosensitizing agents to target malignant tumors, including breast cancer, lung cancer, and T-cell lymphoma. This therapy not only addresses the financial burden of cancer treatments but also aligns with the efforts of cancer registries and national health boards such as the National Board of Health and Welfare. With its efficacy in combating UV light-induced damage, PDT continues to gain prominence in the medical community.

Segment Overview

The market research and growth report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Application Outlook (USD Billion, 2017 - 2027)
    • Cancer
    • Actinic keratosis
    • Psoriasis
    • Acne
    • Others
  • Product Outlook (USD Billion, 2017 - 2027)
    • Photosensitizer drugs
    • Photodynamic therapy devices
  • Region Outlook (USD Billion, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • ROW
      • Argentina
      • Brazil
      • Australia

Photodynamic Therapy Market Scope

Market Report Coverage

Details

Page number

150

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 8.22%

Market growth 2023-2027

USD 2.05 billion

Market structure

Fragmented

YoY growth 2022-2023(%)

7.45

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 36%

Key countries

US, UK, Germany, France, and China

Competitive landscape

Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks

Key companies profiled

Bausch Health Co. Inc., Biofrontera AG, BIOLASE Inc., biolitec AG, Galderma SA, II VI Inc., IRIDEX Corp., Lotus Global Group Inc., LUMIBIRD SA, Lutronic Inc, Modulight Inc., Photocure ASA, Pinnacle Biologics Inc., Quanta Systems Spa, Soligenix Inc., SpectraCure AB, Sun Pharmaceutical Industries Ltd., SUS Advancing Technology Co. Ltd., Theralase Technologies Inc., and Eufoton srl

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our market growth and forecasting report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the growth of the market between 2023 and 2027.
  • Precise estimation of the market size and its contribution to the market in focus on the parent market
  • Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
  • Vendor landscape comparing criticality of inputs and factors of differentiation
  • Exclusive Matrix on vendor position and Classification
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information about companies
  • Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global photodynamic therapy market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global photodynamic therapy market 2017 - 2021 ($ billion)
    • 4.2 Application Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Application Segment 2017 - 2021 ($ billion)
    • 4.3 Product Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Product Segment 2017 - 2021 ($ billion)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Application

    • 6.1 Market segments
      • Exhibit 30: Chart on Application - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
    • 6.2 Comparison by Application
      • Exhibit 32: Chart on Comparison by Application
      • Exhibit 33: Data Table on Comparison by Application
    • 6.3 Cancer - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Cancer - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 35: Data Table on Cancer - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 36: Chart on Cancer - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Cancer - Year-over-year growth 2022-2027 (%)
    • 6.4 Actinic keratosis - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Actinic keratosis - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 39: Data Table on Actinic keratosis - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 40: Chart on Actinic keratosis - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Actinic keratosis - Year-over-year growth 2022-2027 (%)
    • 6.5 Psoriasis - Market size and forecast 2022-2027
      • Exhibit 42: Chart on Psoriasis - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 43: Data Table on Psoriasis - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 44: Chart on Psoriasis - Year-over-year growth 2022-2027 (%)
      • Exhibit 45: Data Table on Psoriasis - Year-over-year growth 2022-2027 (%)
    • 6.6 Acne - Market size and forecast 2022-2027
      • Exhibit 46: Chart on Acne - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 47: Data Table on Acne - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 48: Chart on Acne - Year-over-year growth 2022-2027 (%)
      • Exhibit 49: Data Table on Acne - Year-over-year growth 2022-2027 (%)
    • 6.7 Others - Market size and forecast 2022-2027
      • Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
      • Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
    • 6.8 Market opportunity by Application
      • Exhibit 54: Market opportunity by Application ($ billion)
      • Exhibit 55: Data Table on Market opportunity by Application ($ billion)

    7 Market Segmentation by Product

    • 7.1 Market segments
      • Exhibit 56: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 57: Data Table on Product - Market share 2022-2027 (%)
    • 7.2 Comparison by Product
      • Exhibit 58: Chart on Comparison by Product
      • Exhibit 59: Data Table on Comparison by Product
    • 7.3 Photosensitizer drugs - Market size and forecast 2022-2027
      • Exhibit 60: Chart on Photosensitizer drugs - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 61: Data Table on Photosensitizer drugs - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 62: Chart on Photosensitizer drugs - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on Photosensitizer drugs - Year-over-year growth 2022-2027 (%)
    • 7.4 hotodynamic therapy devices - Market size and forecast 2022-2027
      • Exhibit 64: Chart on hotodynamic therapy devices - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 65: Data Table on hotodynamic therapy devices - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 66: Chart on hotodynamic therapy devices - Year-over-year growth 2022-2027 (%)
      • Exhibit 67: Data Table on hotodynamic therapy devices - Year-over-year growth 2022-2027 (%)
    • 7.5 Market opportunity by Product
      • Exhibit 68: Market opportunity by Product ($ billion)
      • Exhibit 69: Data Table on Market opportunity by Product ($ billion)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 71: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 72: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 73: Chart on Geographic comparison
      • Exhibit 74: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 UK - Market size and forecast 2022-2027
      • Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.9 Germany - Market size and forecast 2022-2027
      • Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.10 China - Market size and forecast 2022-2027
      • Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.11 France - Market size and forecast 2022-2027
      • Exhibit 107: Chart on France - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 108: Data Table on France - Market size and forecast 2022-2027 ($ billion)
      • Exhibit 109: Chart on France - Year-over-year growth 2022-2027 (%)
      • Exhibit 110: Data Table on France - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 111: Market opportunity by geography ($ billion)
      • Exhibit 112: Data Tables on Market opportunity by geography ($ billion)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 113: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 115: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 116: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 117: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 118: Matrix on vendor position and classification
            • 12.3 Bausch Health Co. Inc.
              • Exhibit 119: Bausch Health Co. Inc. - Overview
              • Exhibit 120: Bausch Health Co. Inc. - Business segments
              • Exhibit 121: Bausch Health Co. Inc. - Key news
              • Exhibit 122: Bausch Health Co. Inc. - Key offerings
              • Exhibit 123: Bausch Health Co. Inc. - Segment focus
            • 12.4 Biofrontera AG
              • Exhibit 124: Biofrontera AG - Overview
              • Exhibit 125: Biofrontera AG - Product / Service
              • Exhibit 126: Biofrontera AG - Key offerings
            • 12.5 BIOLASE Inc.
              • Exhibit 127: BIOLASE Inc. - Overview
              • Exhibit 128: BIOLASE Inc. - Product / Service
              • Exhibit 129: BIOLASE Inc. - Key offerings
            • 12.6 biolitec AG
              • Exhibit 130: biolitec AG - Overview
              • Exhibit 131: biolitec AG - Product / Service
              • Exhibit 132: biolitec AG - Key offerings
            • 12.7 Galderma SA
              • Exhibit 133: Galderma SA - Overview
              • Exhibit 134: Galderma SA - Product / Service
              • Exhibit 135: Galderma SA - Key news
              • Exhibit 136: Galderma SA - Key offerings
            • 12.8 II VI Inc.
              • Exhibit 137: II VI Inc. - Overview
              • Exhibit 138: II VI Inc. - Business segments
              • Exhibit 139: II VI Inc. - Key news
              • Exhibit 140: II VI Inc. - Key offerings
              • Exhibit 141: II VI Inc. - Segment focus
            • 12.9 IRIDEX Corp.
              • Exhibit 142: IRIDEX Corp. - Overview
              • Exhibit 143: IRIDEX Corp. - Product / Service
              • Exhibit 144: IRIDEX Corp. - Key offerings
            • 12.10 Lotus Global Group Inc.
              • Exhibit 145: Lotus Global Group Inc. - Overview
              • Exhibit 146: Lotus Global Group Inc. - Product / Service
              • Exhibit 147: Lotus Global Group Inc. - Key offerings
            • 12.11 LUMIBIRD SA
              • Exhibit 148: LUMIBIRD SA - Overview
              • Exhibit 149: LUMIBIRD SA - Product / Service
              • Exhibit 150: LUMIBIRD SA - Key offerings
            • 12.12 Lutronic Inc
              • Exhibit 151: Lutronic Inc - Overview
              • Exhibit 152: Lutronic Inc - Product / Service
              • Exhibit 153: Lutronic Inc - Key offerings
            • 12.13 Modulight Inc.
              • Exhibit 154: Modulight Inc. - Overview
              • Exhibit 155: Modulight Inc. - Product / Service
              • Exhibit 156: Modulight Inc. - Key offerings
            • 12.14 Soligenix Inc.
              • Exhibit 157: Soligenix Inc. - Overview
              • Exhibit 158: Soligenix Inc. - Business segments
              • Exhibit 159: Soligenix Inc. - Key offerings
              • Exhibit 160: Soligenix Inc. - Segment focus
            • 12.15 Sun Pharmaceutical Industries Ltd.
              • Exhibit 161: Sun Pharmaceutical Industries Ltd. - Overview
              • Exhibit 162: Sun Pharmaceutical Industries Ltd. - Product / Service
              • Exhibit 163: Sun Pharmaceutical Industries Ltd. - Key offerings
            • 12.16 SUS Advancing Technology Co. Ltd.
              • Exhibit 164: SUS Advancing Technology Co. Ltd. - Overview
              • Exhibit 165: SUS Advancing Technology Co. Ltd. - Product / Service
              • Exhibit 166: SUS Advancing Technology Co. Ltd. - Key offerings
            • 12.17 Theralase Technologies Inc.
              • Exhibit 167: Theralase Technologies Inc. - Overview
              • Exhibit 168: Theralase Technologies Inc. - Key offerings

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 169: Inclusions checklist
                • Exhibit 170: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 171: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 172: Research methodology
                • Exhibit 173: Validation techniques employed for market sizing
                • Exhibit 174: Information sources
              • 13.5 List of abbreviations
                • Exhibit 175: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              photodynamic therapy market market

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis